ARC Document Solutions (ARC) Stock

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) ARC-EX System is the first and only FDA approved technology shown to improve hand strength and sensation after chronic spinal cord injury ARC-EX System is an FDA Breakthrough Device and 2024 TIME Magazine Best Invention EINDHOVEN, the Netherlands, Dec. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announced that it has received de novo classification and authorization to market its ARC-EX System from the US Food and Drug Administration (FDA).

BIRMINGHAM, Ala.--(BUSINESS WIRE)--On October 15, 2024, the Association of Related Churches (ARC) once again hosted a powerful and unifying Gather Conference. With 16 simultaneous events held across 12 U.S. cities and 4 Canadian locations, this year's conference attracted over 3,000 church leaders, pastors, staff, and volunteers, all of whom are deeply committed to building relationships and gaining valuable resources to support the growth and vitality of local churches. The ARC Gather Conferen.

PETACH TIKVA, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Nanox.ARC, a stationary X-ray system intended to produce tomographic images for general use including human musculoskeletal system, pulmonary, intra-abdominal, and paranasal sinus indications, adjunctive to conventional radiography, on adult patients.

Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke Funding also supports technology development of ARC-BCI System and ARC-IM Lead Approximately 15 million people worldwide experience a stroke each year EINDHOVEN, the Netherlands, Nov. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a grant from the European Innovation Council (EIC) to study the use of its investigational ARC-BCI Therapy to restore upper limb movement after subcortical stroke.

Aqua Metals Inc (NASDAQ:AQMS) reported third-quarter results, detailing progress in lithium recycling, financing initiatives, and preparations for its Sierra AquaRefining Campus (ARC) in Nevada. The company's pilot facility has maintained 24-hour operations, producing lithium carbonate at over 99.5% purity, and claims to be the only US recycler delivering kilogram-scale quantities of battery-grade recycled lithium carbonate, demonstrating its Li AquaRefining technology's scalability.

Attachie project, now online, is boosting ARC's production with premium-priced condensates, which, together with rising gas prices, more than doubling the 2025 FCF compared to 2024. Despite the recent rise in share price, ARC remains undervalued, with a price target in the range of C$30-35 (upside ~30%). LNG contracts are adding exposure to international gas pricing, potentially significantly boosting ARC's FCF.

ARC Document Solutions (ARC) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.06. This compares to earnings of $0.07 per share a year ago.

SAN RAMON, CA / ACCESSWIRE / November 4, 2024 / ARC Document Solutions, Inc. (NYSE:ARC), a leading provider of digital printing and document-related services, today reported its financial results for the third quarter ended September 30, 2024. Financial Highlights: Three Months Ended Nine Months Ended September 30, September 30, (All dollar amounts in millions, except EPS) 2024 2023 2024 2023 Net sales $ 74.4 $ 71.1 $ 220.4 $ 212.3 Gross margin 33.3 % 34.0 % 33.6 % 34.0 % Net (loss) income attributable to ARC $ (0.1 ) $ 3.2 $ 5.5 $ 9.1 Adjusted net income attributable to ARC $ - $ 3.2 $ 5.9 $ 9.4 Earnings per share - diluted $ - $ 0.07 $ 0.13 $ 0.21 Adjusted earnings per share - diluted $ - $ 0.07 $ 0.14 $ 0.22 Cash provided by operating activities $ 9.1 $ 8.7 $ 19.2 $ 22.9 EBITDA1 $ 5.6 $ 9.4 $ 22.5 $ 28.2 Adjusted EBITDA1 $ 6.2 $ 10.0 $ 24.5 $ 29.8 Transaction costs $ 3.2 $ - $ 4.1 $ - Capital expenditures $ 4.0 $ 3.2 $ 10.9 $ 7.7 Debt & finance leases (including current) $ 59.1 $ 62.2 2024Third Quarter Supplemental Information: Net sales were $74.4 million, a 4.8%increase compared to the third quarter of 2023.

NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ARC Document Solutions, Inc. (NYSE:ARC) to TechPrint Holdings, LLC, an affiliate of ARC executives, for $3.40 per share is fair to ARC shareholders. Halper Sadeh encourages ARC shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].